PPD Screening and Treatment: Is There Room for Improvement? A New Study at Mass General Brigham
Announcing a new CWMH study on postpartum depression screening and treatment outcomes at Mass General Brigham.
Announcing a new CWMH study on postpartum depression screening and treatment outcomes at Mass General Brigham.
Family history of psychiatric illness was associated a twofold increased risk for postpartum depression.
This task force does not recommend universal, instrument-based screening for perinatal depression because we lack clear evidence that screening improves outcomes.
Family history of psychiatric illness, especially bipolar disorder, was associated with a signifiant increase in risk for postpartum depression.
Women with postpartum psychosis are at risk for recurrent illness, but we have limited data regarding risk factors for recurrence.
Fathers may also suffer from perinatal depression and paternal depression, just like maternal depression, can have negative effects.
Changes in maternal sleep and circadian rhythms during pregnancy are associated with infant sleep problems and maternal depression and anxiety.
Risk of PPD is low in women who successfully conceive.
Zuranolone has antidepressant effects in women with severe PPD, observed as early as 3 days after initiation of treatment. Â
Using a wearable device to track daily symptoms of postpartum depression was viewed as acceptable and clinically useful by participants and clinicians.